S-1/A: Danam Health Secures $250,000 Promissory Note Amidst IPO Preparations

Danam Health, Inc. has obtained a $250,000 promissory note from Strategic EP LLC, with repayment contingent on future financing or a set maturity date.

Summary

• Danam Health, Inc. secured a $250,000 promissory note from Strategic EP LLC on January 12, 2024.
• The note carries a 2% annual interest rate.
• Repayment of the principal and accrued interest is due either two business days after the company receives $1.5 million or more in financing from sources other than the Holder, or on May 18, 2024, whichever is earlier.
• The principal amount is subject to adjustment as outlined in Section 6 of the note.
• The note is unsecured and can be prepaid by the company without penalty.
• Events of default include non-payment, breach of covenants, breach of representations, illegality of the note, or bankruptcy.
• In the event of default, the Holder can demand immediate payment of all obligations.
• The note is governed by Delaware law and includes a waiver of jury trial.

Sentiment

Score: 6

Explanation: The document is neutral in sentiment. It outlines a financial transaction with both positive and negative aspects. The low interest rate is a positive, but the unsecured nature and potential for default are negative.

Positives

• The company has secured additional funding through a promissory note.
• The note allows for prepayment without penalty, providing flexibility.
• The note has a relatively low interest rate of 2%.

Negatives

• The note is unsecured, meaning the lender has no specific assets to claim in case of default.
• The company is obligated to repay the note in full by May 18, 2024, if the financing condition is not met.
• The note includes several events of default that could trigger immediate repayment.

Risks

• The company may face challenges in securing the $1.5 million in financing needed to avoid the May 18, 2024 maturity date.
• A breach of covenants or representations could trigger an event of default and immediate repayment.
• The company's financial stability is crucial to avoid bankruptcy, which would also trigger an event of default.
• The note is unsecured, increasing the risk for the lender.

Future Outlook

The company's ability to repay the note depends on securing $1.5 million in financing before May 18, 2024, or having sufficient funds to repay the note by the maturity date.

Management Comments

• The document includes a signature from Surendra Ajjarapu, Chief Executive Officer of Danam Health, Inc.

Industry Context

This promissory note is a common financing tool for companies, especially those in the early stages of development or preparing for an IPO. The terms of the note, including the interest rate and maturity date, are typical for this type of financing.

Comparison to Industry Standards

• The 2% interest rate is relatively low for an unsecured promissory note, suggesting the lender may have a strong belief in the company's potential or a pre-existing relationship with the company.
• The repayment terms are structured to incentivize the company to secure additional financing, which is a common practice in venture capital and private equity deals.
• The inclusion of specific events of default is standard practice in promissory notes to protect the lender's interests.

Stakeholder Impact

• Shareholders: The note provides additional funding but also introduces repayment obligations.
• Lender: The lender faces risk due to the unsecured nature of the note but has the potential for a return on investment.
• Employees: The note may provide financial stability for the company, potentially impacting job security.

Next Steps

• Danam Health, Inc. needs to secure $1.5 million in financing to avoid the May 18, 2024 maturity date.
• The company must adhere to all covenants and representations to avoid an event of default.

Key Dates

Keywords

promissory note, financing, Danam Health, Strategic EP LLC, unsecured debt, interest rate, maturity date, default, repayment